Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer (Q73900850)
scientific article published on 01 June 2000
Language:
Current Data About Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer
(P31) (Q13442814)
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P304) 2419-2426
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P407) (Q1860)

(P433) 12
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P478) 18
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P577) Thursday, June 1, 2000
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P921) (Q42824440)
(P887)

(Q238512)
(P887)

(P1433) (Q400292)
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P1476) "Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer" (language: en)
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

(P2093) B I Rini
(P1545) 1
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

N J Vogelzang
(P1545) 2
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

M C Dumas
(P1545) 3
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

J L Wade
(P1545) 4
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

D A Taber
(P1545) 5
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

W M Stadler
(P1545) 6
(P248)
(P698) 10856102
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10856102%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, November 7, 2019

other details
description scientific article published on 01 June 2000

External Links
(P356) 10.1200/JCO.2000.18.12.2419
(P698) 10856102